Dermata Therapeutics- Warrants (13/08/2026) Net Tangible Assets

As of the most recent data (June 2026), DRMAW shows a net tangible assets of $3.5M. That compares with $5.6M in the prior-year period — down 37.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DRMAW's net tangible assets is now $3.5M (was $5.6M) — a 37.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Dermata Therapeutics- Warrants (13/08/2026) is outperforming or lagging.

Tracking DRMAW's net tangible assets over time shows whether Dermata Therapeutics- Warrants (13/08/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $3.5M That compares with $5.6M in the prior-year period — down 37.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Dermata Therapeutics- Warrants (13/08/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $3.5M) with ownership activity and broader fundamentals.

Dermata Therapeutics- Warrants (13/08/2026)'s net tangible assets is $3.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.